MDNA — Medicenna Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$213.12m
- CA$191.36m
- 46
- 14
- 91
- 49
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4.71 | -8.28 | -17.3 | -22.6 | -10 |
Depreciation | |||||
Non-Cash Items | -4.02 | 0.107 | 1.26 | 0.799 | -5.02 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.654 | -0.793 | 0.68 | -1.84 | 2.41 |
Change in Accounts Receivable | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -8.07 | -8.95 | -15.3 | -23.6 | -12.7 |
Other Investing Cash Flow Items | -0.354 | -15 | 5.01 | 10.1 | 0 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.354 | -15 | 5.01 | 10.1 | 0 |
Financing Cash Flow Items | 3.24 | 3.54 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 6.82 | 44.3 | 18.3 | 3.88 | 24.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.57 | 20.3 | 7.68 | -9.84 | 13.1 |